{"body":"

Drug companies are accelerating the development of ketamine medicines in response to a renewed interest in psychedelic therapies sparked by the Trump administration. A NY Times Health article notes that the federal government’s endorsement of psychedelic research has prompted a wave of investment in ketamine-based treatments.

Ketamine, long used as an anesthetic, is now being explored for a range of therapeutic applications. Researchers are experimenting with both new formulations and existing variants of the drug, seeking ways to enhance efficacy, reduce side effects, and broaden the conditions for which ketamine can be prescribed.

The Trump administration’s embrace of psychedelic medicine has lifted regulatory barriers and increased funding for clinical studies. This shift has created a climate in which pharmaceutical companies can pursue ketamine products with greater confidence, knowing that public and governmental support is growing for novel psychiatric therapies.

As companies race to bring ketamine medicines to market, the rapid pace of development could reshape mental‑health care in the coming years, offering new options for patients who have limited access to traditional treatments.

","key_points":["Drug companies are accelerating the development of ketamine medicines in response to renewed interest in psychedelic therapies.","The Trump administration’s support for psychedelic medicine has encouraged research into ketamine-based treatments.","Researchers are experimenting with both new and existing forms of the anesthetic to improve therapeutic outcomes.","The rapid development of ketamine medicines may reshape mental‑health care in the near future."],"faq":[{"question":"What has prompted drug companies to speed up ketamine medicine development?","answer":"The Trump administration’s endorsement of psychedelic medicine has spurred increased research and investment in ketamine-based treatments."},{"question":"Why are researchers exploring new and existing forms of ketamine?","answer":"They seek to enhance efficacy, reduce side effects, and expand the range of conditions that ketamine can treat."},{"question":"What could happen next in the development of ket